Blocking Skp2 protein might inhibit glycolysis and treat breast cancer
 

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

More...